John H. Noseworthy, MD, is president and chief executive officer of Mayo Clinic, a not-for-profit organisation operating in six American states that is dedicated to medical care, research and education. He obtained his MD degree from Dalhousie University in Halifax, Nova Scotia, Canada. Dr. Noseworthy completed his neurology training at Dalhousie University and the University of Western Ontario, and a research fellowship at Harvard Medical School.
Prior to his current position, Dr. Noseworthy served as chair of Mayo Clinicís Department of Neurology, medical director of the Department of Development, and vice chair of the Mayo Clinic Rochester Executive Board. He joined Mayo Clinic in 1990.
Mayo Clinic provides care services to more than a million people from the U.S. and nearly 150 countries each year. The Clinic is "committed to providing the best care for every patient every day," its CEO says. Under Dr. Noseworthy's leadership, Mayo Clinic has launched new initiatives including a proton beam cancer therapy programme and development of a Mayo Clinic-affiliate network of high-quality medical practices throughout the country.
Dr. Noseworthy is concurrently a professor in the Department of Neurology. He specialises in multiple sclerosis and has spent more than two decades designing and conducting controlled clinical trials with generous support from the Multiple Sclerosis Society of Canada, the Medical Research Council of Canada, the National Multiple Sclerosis Society (USA) and the National Institutes of Health.
A published writer, Dr. Noseworthy is the author of more than 150 research papers, chapters and editorials. His books include the three-volume textbook Neurological Therapeutics: Principles and Practice, now in its second edition. Previously, he served as editor-in-chief for Neurology, the official journal of the American Academy of Neurology.
Dr. Noseworthy also is a Health Governor of the World Economic Forum.
Sources: Mayo Clinic and Wall Street Journal
Prior to his current position, Dr. Noseworthy served as chair of Mayo Clinicís Department of Neurology, medical director of the Department of Development, and vice chair of the Mayo Clinic Rochester Executive Board. He joined Mayo Clinic in 1990.
Mayo Clinic provides care services to more than a million people from the U.S. and nearly 150 countries each year. The Clinic is "committed to providing the best care for every patient every day," its CEO says. Under Dr. Noseworthy's leadership, Mayo Clinic has launched new initiatives including a proton beam cancer therapy programme and development of a Mayo Clinic-affiliate network of high-quality medical practices throughout the country.
Dr. Noseworthy is concurrently a professor in the Department of Neurology. He specialises in multiple sclerosis and has spent more than two decades designing and conducting controlled clinical trials with generous support from the Multiple Sclerosis Society of Canada, the Medical Research Council of Canada, the National Multiple Sclerosis Society (USA) and the National Institutes of Health.
A published writer, Dr. Noseworthy is the author of more than 150 research papers, chapters and editorials. His books include the three-volume textbook Neurological Therapeutics: Principles and Practice, now in its second edition. Previously, he served as editor-in-chief for Neurology, the official journal of the American Academy of Neurology.
Dr. Noseworthy also is a Health Governor of the World Economic Forum.
Sources: Mayo Clinic and Wall Street Journal
Latest Articles
Mayo Clinic, Zoom On
John H. Noseworthy, MD, is president and chief executive officer of Mayo Clinic, a not-for-profit organisation operating in six American states that is ded...
